Insulin lispro-aabc

FDA Drug Profile — LYUMJEV KwikPen, LYUMJEV, LYUMJEV Junior KwikPen, LYUMJEV Tempo Pen

Drug Details

Generic Name
Insulin lispro-aabc
Brand Names
LYUMJEV KwikPen, LYUMJEV, LYUMJEV Junior KwikPen, LYUMJEV Tempo Pen
Application Number
BLA761109
Sponsor
Eli Lilly and Company
NDC Codes
13
Dosage Forms
INJECTION, SOLUTION
Routes
SUBCUTANEOUS, INTRAVENOUS
Active Ingredients
INSULIN LISPRO

Indications and Usage

1 INDICATIONS AND USAGE LYUMJEV ® is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. LYUMJEV ® is a rapid-acting human insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. ( 1 )